SPDR S&P Biotech ETF Sees Unusually Large Options Volume (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) saw some unusual options trading activity on Wednesday. Traders bought 132,442 put options on the company. This is an increase of 33% compared to the typical daily volume of 99,395 put options.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $87.35 on Thursday. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52. The company has a 50-day simple moving average of $92.38 and a 200 day simple moving average of $85.04. The company has a market capitalization of $6.79 billion, a PE ratio of 11.47 and a beta of 1.08.

Hedge Funds Weigh In On SPDR S&P Biotech ETF

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Avoro Capital Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $396,844,000. Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of SPDR S&P Biotech ETF by 35.9% in the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,406,000 shares of the exchange traded fund’s stock valued at $214,832,000 after acquiring an additional 635,000 shares during the period. Phoenix Holdings Ltd. boosted its position in shares of SPDR S&P Biotech ETF by 0.8% in the third quarter. Phoenix Holdings Ltd. now owns 2,151,359 shares of the exchange traded fund’s stock valued at $157,092,000 after acquiring an additional 17,221 shares during the period. Migdal Insurance & Financial Holdings Ltd. bought a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $102,900,000. Finally, Bank Julius Baer & Co. Ltd Zurich boosted its position in shares of SPDR S&P Biotech ETF by 4.4% in the third quarter. Bank Julius Baer & Co. Ltd Zurich now owns 627,917 shares of the exchange traded fund’s stock valued at $45,850,000 after acquiring an additional 26,728 shares during the period.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.